Publicaciones (33) Publicaciones de Juan Antonio González Díaz

2020

  1. Design and implementation of a teaching project for the formation of medical identity in medical students

    Educacion Medica, Vol. 21, Núm. 3, pp. 207-211

2016

  1. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663

2014

  1. Gobierno y organización en la Universidad: relaciones entre autoridad y poder

    Revista empresa y humanismo, Vol. 17, Núm. 2, pp. 61-74

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy

    Journal of Surgical Oncology, Vol. 104, Núm. 2, pp. 124-129

  2. Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444

  3. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

  4. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach

    Clinical and Translational Oncology, Vol. 13, Núm. 12, pp. 899-903

2010

  1. Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

    BMC Cancer, Vol. 10

  2. Moving towards a more comprehensive vision of GI cancer

    Clinical and Translational Oncology

  3. Updating controversies on the multidisciplinary management of gastric cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 10, pp. 677-685

2009

  1. The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

    British Journal of Cancer, Vol. 100, Núm. 6, pp. 932-940

  2. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

  2. cT3N0 rectal cancer: Potential overtreatment with preoperative chemoradiotherapy is warranted

    Journal of Clinical Oncology, Vol. 26, Núm. 3, pp. 368-373

2007

  1. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy

    Annals of Surgical Oncology, Vol. 14, Núm. 5, pp. 1744-1751

  2. Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole

    Cancer Biology and Therapy, Vol. 6, Núm. 1, pp. 70-75

  3. Rectal cancer treatment: Improving the picture

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5805-5812

2006

  1. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

    Annals of Oncology, Vol. 17, Núm. 7, pp. 1103-1110

  2. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation

    International Journal of Radiation Oncology Biology Physics, Vol. 64, Núm. 4, pp. 1122-1128